Qube Research & Technologies »

Viracta Therapeutics shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Viracta Therapeutics (VIRX) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Viracta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viracta Therapeutics held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viracta Therapeutics by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $2 2 1.00
2022-09-30 $116k 27k 4.26
2022-06-30 $120k 31k 3.88
2021-03-31 $96k 10k 9.30

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Viracta Therapeutics

BVF
Citadel Advisors
Vanguard Group
Samsara BioCapital
Laurion Capital Management
MAI Wealth Advisors
Aisling Capital Management
UBS Group
Squarepoint Ops
Virtu Financial
United Bank
Two Sigma Securities
Integrys Wealth Advisors
HoyleCohen
Trust Co Of Toledo Na

View all funds holding Viracta Therapeutics